top of page


Daniel Offen, Ph.D.

Principle Investigator


Daniel Offen

Head, The Neuroscience Laboratory

Felsenstein Medical Research Center

Dept. of Human Molecular Genetics and Biochemistry,

Sackler Faculty of Medicine

Sagol school of Neuroscience

Tel Aviv University





Daniel Offen studied molecular biology, specializing in RNA  processing, at the Weizmann Institute of Science, Israel. He furthered his education at the Albert Einstein College of Medicine, NY, USA, as a Post Doctoral Fellow where he developed transgenic models of autoimmunity. For many years, Offen has headed The Laboratory for Neurosciences at the Felsenstein Medical Research Center, Tel Aviv University. His work has concentrated on the processes of cell death in neurodegenerative diseases, specifically in Parkinson's and ALS. Recently, Professor Offen and his group have conducted pioneering work in the role of stem cells in health and disease. Offen's research has led to the publication of more than two hundred original articles, review papers and book chapters.

Prof. Offen is a co-founder of several biotechnology companies developing gene and cell therapies for neurological disorders. One of them, Brainstorm Cell Therapeutics, showed efficacy in ALS patients in a Phase III clinical trial.




1980-1982 B.Sc. Faculty of Agriculture

The Hebrew University, Jerusalem


1985-1989 Ph.D. Feinberg Graduate School

The Weizmann Institute of Science, Rehovot


1989-1991 Postdoctoral Fellowship

Albert Einstein College of Medicine, New York, USA



Academic Position

Full Professor, Department of Human Genetics and Molecular Medicine, Sackler School of Medicine 

Sagol School of Neuroscience

Tel Aviv University, Israel




bottom of page